Status:
COMPLETED
Effects of Dexmedetomidine vs Propofol in Patients With Intra-abdominal Sepsis
Lead Sponsor:
Assiut University
Conditions:
Septic Peritonitis
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
Sepsis is defined as systemic response to infection ,and it is a main problem in ICU and despite advance in supportive care, the mortality rate in patients with severe sepsis continues to exceed 30% \...
Detailed Description
After surgery patients will be transferred to the ICU and will be randomly allocated by use of sealed envelopes ;into one of three groups 20 patients each. All ICU measurements will be recorded by an...
Eligibility Criteria
Inclusion
- patients aged18 years old or more and had the criteria of intraabdominal sepsis as evident by quick sofa score of 2 or more and have done intraabdominal surgical procedures
Exclusion
- children pregnant women Patients who receive neuromascular blockers during the first 48 hours of ICU admission known allergy or contraindication to propofol ,dexemedetomidine or midazolam known or suspected brain death
Key Trial Info
Start Date :
January 23 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 10 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04718714
Start Date
January 23 2021
End Date
April 10 2021
Last Update
April 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Assiut University
Asyut, Egypt, 71515